期刊文献+

环氧化酶-2基因-765G>C多态性与老年代谢综合征患者阿司匹林抵抗无关 被引量:4

Cyclooxygenase-2 Gene-765G>C Polymorphism is NOT Associated with Aspirin Resistance in Elderly Patients with Metabolic Syndrome
原文传递
导出
摘要 目的探讨老年代谢综合征患者阿司匹林抵抗的罹患率及其与环氧化酶-2(COX-2)基因-765G>C多态性的关系。方法 106位老年代谢综合征患者口服阿司匹林100mg/d至少20天,根据Chrono-log560CA全血发光血小板聚集系统检测结果分为阿司匹林抵抗(AR)组或阿司匹林敏感(AS)组,然后应用聚合酶链反应和限制性片段长度多态性(PCR-RFLP)技术分析COX-2基因-765G>C多态性。结果老年代谢综合征患者中阿司匹林抵抗的罹患率为31.13%,-765G>C多态性三种基因型GG、GC和CC的分布频率分别为68.9%、22.6%和8.5%,-765C等位基因分布频率为19.8%。AR和AS两组患者-765G>C多态性的基因型(p=0.553)和等位基因(p=0.714)分布频率没有显著差异。结论 COX-2基因-765G>C多态性与老年代谢综合征患者阿司匹林抵抗无关。 Objective To investigate the prevalence of aspirin resistance and its relationship with cyclooxygenase-2(COX-2) gene-765G>C polymorphism in elderly patients with metabolic syndrome.Methods We recruited 106 elderly patients with metabolic syndrome in this study.After taking aspirin 100mg/d for at least 20 days,they were divided into aspirin resistance(AR) group or aspirin sensitive(AS)group according to the platelet activity determined by whole blood aggregometry Chrono-log 560CA.The COX-2 gene-765G>C ...
出处 《中国分子心脏病学杂志》 CAS 2011年第3期164-168,共5页 Molecular Cardiology of China
基金 山东省卫生厅医药卫生计划基金(2007HW096) 国家自然科学青年基金(30900608) 山东省自然科学基金(ZR2010HQ048) 山东大学青年科技明星计划(20080112)
关键词 环氧化酶-2 多态性 代谢综合征 阿司匹林抵抗 Cyclooxygenase-2 Polymorphism Metabolic Syndrome Aspirin Resistance
  • 相关文献

参考文献9

二级参考文献57

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:195
  • 2吕树铮,宋现涛,陈韵岱,陈欣,中国经皮冠状动脉介入治疗登记调查研究协作组.中国大陆2005年度经皮冠状动脉介入治疗登记调查研究结果初步分析[J].中华心血管病杂志,2006,34(11):966-970. 被引量:43
  • 3李春蓉,陈智杰.冠心病患者阿司匹林抵抗的临床特征分析[J].现代中西医结合杂志,2007,16(3):305-306. 被引量:3
  • 4Michelson AD, Frelinger AL 3rd, Furman MI. Current options in platelet function testing. Am J Cardiol,2006,98(10A) :4N-10N.
  • 5Harrison P, Frelinger AL 3rd, Furman MI, et al. Measuring antiplatelet drug effects in the laboratory. Thromb Res,2007,120:323-336.
  • 6Uchiyama S, Nakamura T, Yamazaki M, et al. Platelet activation and antiplatelet therapy in patients with ischemic stroke. International Congress Series ,2003, 1251:57-70.
  • 7Marzilli M, Sambuceti G, Testa R, et al. Platelet glycoprotein Ⅱb/Ⅲ a receptor blockade and coronary resistance in unstable angina. J Am Coll Cardiol,2002 ,40 :2102-2109.
  • 8Rand ML, Leung R, Packham MA. Platelet function assays. Transfus Apher Sci, 2003,28:307-317.
  • 9Lind SE, Kurkjian CD. The bleeding time. In : Michelson AD, Platelets. 2nd ed. San Diego, CA : Elsevier/Academic Press, 2006 : 485-494.
  • 10Hubl W, Assadian A, Lax J, et al. Assessing aspirin-induced attenuation of platelet reactivity by flow cytometry. Thromb Res,2007,121:135- 143.

共引文献3114

同被引文献43

  • 1Atique S,Bauman C,Seiji R,et al. Aspirin resistance and athero- thrombosis[J]. Braz J Cardiovasc Surg, 2007,22 : 96-103.
  • 2Antithromhotic Trialists(ATT) Collaboration, Batgent C, Black- well L,et al. Aspirin in the pcimary and accondary prevention of vascular disease;collaborative meta-analysis of individual partici- pant data from randomized trials[J]. Lancet, 2009,373: 1849- 1860.
  • 3Berger JS,Kranta M J, Kittelson JM, et a l. Aspirin for the pre- vention of cardiovascular events in patients with peripheral arter- y disease: a meta-analysis of randomized trials [J]. JAMA, 2009, 301(18) : 1909-1919.
  • 4Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update:a report from the American Heart Association [J]. Circulation, 2011, 123(4) : 18-209.
  • 5Hankey GJ, Eikelboom JW. Aspirin Resistance [J]. Lancet, 2006, 367(9510): 606- 617.
  • 6Goodman T,Sharma F. The genetics of aspirin resistance[J]. Int J Clin Pract,2007,61 :826.
  • 7Timothy Goodman, lbert Ferro, ankaj Sharmal. Pharmacogenet- its of aspirin resistance:a comprehensive systematic review[J]. Br J Clin Pharmacol, 2008,66 : 222.
  • 8Kohsaka S,Volcik KA, Folsom AR,et al. Increasedrisk of inci- dent stroke associated with the cyclooxygenase 2 (COX-2) G- 765C polymorphism in Afrcan-Amreicans: the atherosclerosis risk in communities study[J]. Atherosclerosis, 2008,196 : 926- 930.
  • 9Sayer I, AI-Azzam,Karem H,et al. The contribution of platelet glycoproteins(GPla C807T and GPIba C-ST) and cyclooxygen- ase 2(COX-2G-765C) polymorphisms to platelet response in pa- tients treated with aspirin[J]. Gene, 2013, (526) : 119-121.
  • 10Xiao li Li, MD, Jian Cao,et al. Genetic polymorphisms of HO-1 and COX-1 are associated with Aspirin resistance defined by light transmittance aggregation in Chinese Han patients [J]. Clinical and Applied Thrombosis/Hemostasis, 2012,19 ( 5 ) : 513- 521.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部